Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XII.bf

Myopericarditis (see under XIIc/d/g)

Publications

Taha ME, Abdalla A, Al-Khafaji J, Malik S

Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.

Cardiology research. 2019;10(1):59-62

Dias T, Santos A, Santos RM, Carvalho A

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

BMJ case reports. 2019;12(2)

Park EH, Kim BJ, Huh JK, Jeong EH, Lee SH, Bang KB, Seol JS, Sung JW, Kim BS, Kang JH

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

Journal of cardiovascular ultrasound. 2012;20(3):154-6

Freeman HJ, Salh B

Recurrent myopericarditis with extensive ulcerative colitis.

The Canadian journal of cardiology. 2010;26(10):549-50

Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H

Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

International journal of colorectal disease. 2006;21(2):199-200

Camus P, Piard F, Ashcroft T, Gal AA, Colby TV

The lung in inflammatory bowel disease.

Medicine. 1993;72(3):151-83